Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	CM Relapsed/Refractory	11
Overall Study	STARTED	ACM Relapsed/Refractory	79
Overall Study	STARTED	ACM Newly Diagnosed	14
Overall Study	Stage 1	CM Relapsed/Refractory	0
Overall Study	Stage 1	ACM Relapsed/Refractory	32
Overall Study	Stage 1	ACM Newly Diagnosed	10
Overall Study	Stage 2	CM Relapsed/Refractory	11
Overall Study	Stage 2	ACM Relapsed/Refractory	47
Overall Study	Stage 2	ACM Newly Diagnosed	4
Overall Study	COMPLETED	CM Relapsed/Refractory	6
Overall Study	COMPLETED	ACM Relapsed/Refractory	33
Overall Study	COMPLETED	ACM Newly Diagnosed	5
Overall Study	NOT COMPLETED	CM Relapsed/Refractory	5
Overall Study	NOT COMPLETED	ACM Relapsed/Refractory	46
Overall Study	NOT COMPLETED	ACM Newly Diagnosed	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02520011/flow